|
1
|
Qi B, Lu JG, Yao WJ, Chang TM, Qin XG, Ji
YH, Wang TY, Liu SG, Li HC, Liu YZ and Zhao BS: Downregulation of
microRNA-382 is associated with poor outcome of esophageal squamous
cell carcinoma. World J Gastroenterol. 21:6884–6891. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li X, Wu Z, Mei Q, Li X, Guo M, Fu X and
Han W: Long non-coding RNA HOTAIR, a driver of malignancy, predicts
negative prognosis and exhibits oncogenic activity in oesophageal
squamous cell carcinoma. Br J Cancer. 109:2266–2278. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schetter AJ, Okayama H and Harris CC: The
Role of microRNAs in Colorectal Cancer. Cancer J. 18:244–252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S,
Guo X, Wang B, Gang Y, Zhang Y, et al: mir-218 inhibits invasion
and metastasis of gastric cancer by targeting the Robo1 receptor.
PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S,
Lobie PE and Zhu T: c-MYC-regulated miR-23a/24-2/27a cluster
promotes mammary carcinoma cell invasion and hepatic metastasis by
targeting Sprouty2. J Biol Chem. 288:18121–18133. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang GJ, Li JS, Zhou H, Xiao HX, Li Y and
Zhou T: MicroRNA-106b promotes colorectal cancer cell migration and
invasion by directly targeting DLC1. J Exp Clin Cancer Res.
34:732015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yau WL, Lam CS, Ng L, Chow AK, Chan ST,
Chan JY, Wo JY, Ng KT, Man K, Poon RT and Pang RW: Over-expression
of miR-106b promotes cell migration and metastasis in
hepatocellular carcinoma by activating epithelial-mesenchymal
transition process. PLoS One. 8:e578822013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Y, Hu Y, Yang M, Jat P, Li K,
Lombardo Y, Xiong D, Coombes RC, Raguz S and Yagüe E: The
miR-106b~25 cluster promotes bypass of doxorubicin-induced
senescence and increase in motility and invasion by targeting the
E-cadherin transcriptional activator EP300. Cell Death Differ.
21:462–474. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang H, Liu J, Zong Y, Xu Y, Deng W, Zhu
H, Liu Y, Ma C, Huang L, Zhang L and Qin C: miR-106b aberrantly
expressed in a double transgenic mouse model for Alzheimer's
disease targets TGF-β type II receptor. Brain Res. 1357:166–174.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ivanovska I, Ball AS, Diaz RL, Magnus JF,
Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson
AL, et al: MicroRNAs in the miR-106b family regulate p21/CDKN1A and
promote cell cycle progression. Mol Cell Biol. 28:2167–2174. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dai F, Liu T, Zheng S, Liu Q, Yang C, Zhou
J, Chen Y, Sheyhidin I and Lu X: miR-106b promotes migration and
invasion through enhancing EMT via downregulation of Smad 7 in
Kazakh's esophageal squamous cell carcinoma. Tumour Biol.
37:14595–14604. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng L, Zhang Y, Liu Y, Zhou M, Lu Y,
Yuan L, Zhang C, Hong M, Wang S and Li X: miR-106b induces cell
radioresistance via the PTEN/PI3K/AKT pathways and p21 in
colorectal cancer. J Transl Med. 13:2522015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Cui J, Zhang CH, Yang DJ, Chen JH,
Zan WH, Li B, Li Z and He YL: High-expression of DJ-1 and loss of
PTEN associated with tumor metastasis and correlated with poor
prognosis of gastric carcinoma. Int J Med Sci. 10:1689–1697. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan T, Jiang X, Guo X, Chen W, Tang D,
Zhang J, Zhang X, Zhang D, Zhang Q, Jia J and Huang Y: Electric
field-induced suppression of PTEN drives epithelial-to-mesenchymal
transition via mTORC1 activation. J Dermatol Sci. 85:96–105. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang T, Xuan X, Li M, Gao P, Zheng Y, Zang
W and Zhao G: Astragalus saponins affect proliferation, invasion
and apoptosis of gastric cancer BGC-823 cells. Diagn Pathol.
8:1792013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harazono Y, Muramatsu T, Endo H, Uzawa N,
Kawano T, Harada K, Inazawa J and Kozaki K: miR-655 is an
EMT-suppressive MicroRNA targeting ZEB1 and TGFBR2. PLoS One.
8:e627572013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qi Q, Ling Y, Zhu M, Zhou L, Wan M, Bao Y
and Liu Y: Promoter region methylation and loss of protein
expression of PTEN and significance in cervical cancer. Biomed Rep.
2:653–658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang W and Luo YP: MicroRNAs in breast
cancer: Oncogene and tumor suppressors with clinical potential. J
Zhejiang Univ Sci B. 16:18–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu M and Mo YY: The Akt-associated
microRNAs. Cell Mol Life Sci. 69:3601–3612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mei LL, Qiu YT, Zhang B and Shi ZZ:
MicroRNAs in esophageal squamous cell carcinoma: Potential
biomarkers and therapeutic targets. Cancer Biomark. 19:1–9. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sakai NS, Samia-Aly E, Barbera M and
Fitzgerald RC: A review of the current understanding and clinical
utility of miRNAs in esophageal cancer. Semin Cancer Biol.
23:512–521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hudson RS, Yi M, Esposito D, Glynn SA,
Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH,
et al: MicroRNA-106b-25 cluster expression is associated with early
disease recurrence and targets caspase-7 and focal adhesion in
human prostate cancer. Oncogene. 32:4139–4147. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li BK, Huang PZ, Qiu JL, Liao YD, Hong J
and Yuan YF: Upregulation of microRNA-106b is associated with poor
prognosis in hepatocellular carcinoma. Diagn Pathol. 9:2262014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang Q, Zhang RW, Sui PC, He HT and Ding
L: Dysregulation of non-coding RNAs in gastric cancer. World J
Gastroenterol. 21:10956–10981. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cai K, Wang Y and Bao X: miR-106b promotes
cell proliferation via targeting RB in laryngeal carcinoma. J Exp
Clin Cancer Res. 30:732011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ni X, Xia T, Zhao Y, Zhou W, Wu N, Liu X,
Ding Q, Zha X, Sha J and Wang S: Downregulation of miR-106b induced
breast cancer cell invasion and motility in association with
overexpression of matrix metalloproteinase 2. Cancer Sci.
105:18–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma F, Li W, Liu C, Li W, Yu H, Lei B, Ren
Y, Li Z, Pang D and Qian C: miR-23a promotes TGF-β1-induced EMT and
tumor metastasis in breast cancer cells by directly targeting CDH1
and activating Wnt/β-catenin signaling. Oncotarget. 8:69538–69550.
2017.PubMed/NCBI
|
|
30
|
Xu W, Yang Z, Zhou SF and Lu N:
Posttranslational regulation of phosphatase and tensin homolog
(PTEN) and its functional impact on cancer behaviors. Drug Des
Devel Ther. 8:1745–1751. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Madhunapantula SV and Robertson GP: The
PTEN-AKT3 Signaling Cascade as a Therapeutic Target in Melanoma.
Pigment Cell Melanoma Res. 22:400–419. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Georgescu MM: PTEN tumor suppressor
network in PI3K-Akt pathway control. Genes Cancer. 1:1170–1177.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ren P, Gong F, Zhang Y, Jiang J and Zhang
H: MicroRNA-92a promotes growth, metastasis, and chemoresistance in
non-small cell lung cancer cells by targeting PTEN. Tumour Biol.
37:3215–25. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng X, Li J, Peng C, Zhao J, Chi J, Meng
X, Yun X, Li D, Yu Y, Gao M and Li Y: MicroRNA-4 induces cisplatin
resistance by targeting PTEN in human tongue squamous cell
carcinoma. Oral Oncol. 51:998–1003. 2015. View Article : Google Scholar : PubMed/NCBI
|
